Please login to the form below

Not currently logged in
Email:
Password:

Indoco and Watson Pharma in deal

Indian company Indoco Remedies has signed a deal with US-based Watson Pharmaceuticals to develop generic products for the US market

Indoco Remedies has signed a deal with US-based Watson Pharmaceuticals to develop generic products for the US market.

Shares of the Mumbai-based Indoco surged 4.95 per cent on the Bombay Stock Exchange after the announcement.

Under this deal, Indoco will develop, manufacture and supply a number of products that currently have yearly sales of $679m.

Indoco's chairman and managing director Suresh G Kare has said it is a remarkable achievement to be out-licensing technology to a company of Watson's scale.

2nd February 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

COVID-19 is redefining the value of ‘critical jobs’: An opportunity for social care?
...
How to keep your weight under control during lockdown
...
Brands stepping up to show solidarity during COVID-19
The brands that are stepping up to show solidarity during COVID-19 will be those that are remembered long after pandemic passes....

Infographics